Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.42 |
| ▸ | ANPEP | P15144 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.39 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.39 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1905381 | 0.98 | SMYD3 (0.47) | SMYD3PLAUGAAMAPTKDM4E | |
| SCHEMBL5420694 | 0.88 | MAPT (0.43) | SMYD3PLAUGAAMAPTKDM4E | |
| SCHEMBL1437747 | 0.79 | PLAU (0.37) | SMYD3PLAUGAAMEN1KMT2A | |
| SCHEMBL5832175 | 0.78 | GAA (0.50) | SMYD3PLAUGAAMAPT | |
| SCHEMBL19774297 | 0.78 | MTNR1A (0.47) | SMYD3PLAUGAAMAPTKDM4E | |
| SCHEMBL20344534 | 0.77 | ANPEP (0.50) | SMYD3PLAUGAAMAPTMTNR1A | |
| SCHEMBL4130897 | 0.75 | MTNR1A (0.45) | SMYD3GAAMAPTMTNR1ANPC1 | |
| SCHEMBL2697405 | 0.75 | MTNR1A (0.45) | SMYD3PLAUGAAMAPTKDM4E | |
| SCHEMBL8771344 | 0.75 | MTNR1A (0.42) | SMYD3PLAUGAAMAPTKDM4E | |
| SCHEMBL13305784 | 0.75 | MTNR1A (0.45) | SMYD3PLAUGAAMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039343-B | Tetrahydroquinoline-amido metal catalyst, preparation method and application thereof | 淄博鲁华泓锦新材料集团股份有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-119039343-A | Tetrahydroquinoline-amido metal catalyst, preparation method and application thereof | 淄博鲁华泓锦新材料集团股份有限公司 | 2024-11-29 | — | — | CN | claimed |
| EP-3694485-A1 | SPECIFIC 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINES, METHOD, AND COMPOSITION | L'OREAL (FR) | 2020-08-19 | — | — | EP | claimed |
| US-20150141877-A1 | LED AND SHOCKWAVE THERAPY FOR TATTOO REMOVAL | INREXREM INC. (US) | 2015-05-21 | — | — | US | claimed |
| US-20140276246-A1 | SYSTEM AND METHOD FOR TATTOO REMOVAL | InrexRem | 2014-09-18 | — | — | US | claimed |
| EP-1651190-B1 | FORMULATIONS CONTAINING AN IMMUNE RESPONSE MODIFIER | 3M INNOVATIVE PROPERTIES CO (US) | 2012-09-19 | — | — | EP | claimed |
| EP-1784185-A4 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 2009-06-03 | — | — | EP | claimed |
| US-7375180-B2 | Methods and compositions related to IRM compounds and Toll-like receptor 8 | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-05-20 | — | — | US | claimed |
| EP-1784185-A2 | CHEMICAL COMPOUNDS | SmithKline Beecham Corporation (US) | 2007-05-16 | — | — | EP | claimed |
| EP-1592302-A4 | METHODS AND COMPOSITIONS RELATED TO IRM COMPOUNDS AND TOLL-LIKE RECEPTOR 8 | 3M INNOVATIVE PROPERTIES CO (US) | 2007-04-25 | — | — | EP | claimed |
| WO-2006130399-A2 | THERAPEUTIC COMBINATIONS AND METHODS INCLUDING IRM COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-12-07 | — | — | WO | claimed |
| WO-2006028896-A2 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2006-03-16 | — | — | WO | claimed |
| EP-1603476-A2 | METHOD OF TATTOO REMOVAL | 3M Innovative Properties Company (US) | 2005-12-14 | — | — | EP | claimed |
| EP-1592302-A2 | METHODS AND COMPOSITIONS RELATED TO IRM COMPOUNDS AND TOLL-LIKE RECEPTOR 8 | 3M Innovative Properties Company (US) | 2005-11-09 | — | — | EP | claimed |
| US-20050226878-A1 | Therapeutic combinations and methods including IRM compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2005-10-13 | — | — | US | claimed |
| CN-1610550-A | Pharmaceutical formulations comprising an immune response modifier | 3M INNOVATIVE PROPERTIES CO (US) | 2005-04-27 | — | — | CN | claimed |
| WO-2004080292-A2 | METHOD OF TATTOO REMOVAL | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-09-23 | — | — | WO | claimed |
| US-20040181211-A1 | Method of tattoo removal | 3M INNOVATIVE PROPERTIES COMPANY | 2004-09-16 | — | — | US | claimed |
| WO-2004071459-A2 | METHODS AND COMPOSITIONS RELATED TO IRM COMPOUNDS AND TOLL-LIKE RECEPTOR 8 | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-08-26 | — | — | WO | claimed |
| US-20040162309-A1 | Methods and compositions related to IRM compounds and toll-like receptor 8 | 3M INNOVATIVE PROPERTIES COMPANY | 2004-08-19 | — | — | US | claimed |